RKLB

RKLB - Rocket Lab Corp

OPPORTUNISTIC BUYAWAIT ENTRYIndustrials - Aerospace & Defense2026-08-09Data 34 days oldUSD 82.83

Conviction

out of 100

Executive Summary

Rocket Lab Corporation (RKLB) is a US-based aerospace company that designs, manufactures and launches small and medium-lift rockets - principally the Electron workhorse and the developing Neutron vehicle - and sells satellite components through its Space Systems division. The company is positioned as the leading dedicated small-launch operator in the West, with a widening foothold in national security launch and on-orbit services.

The investment case rests on Rocket Lab converting two material hard catalysts into sustained revenue growth without execution slippage. The key near-term event is the close of the announced acquisition of Iridium's satellite communications business, alongside conversion of the US Space Force launch contract backlog into booked launches. The principal risk is that loss-making scale-up outpaces the company's ability to manage integration, production and launch cadence, as flagged in the company's own 10-K risk disclosures.

OPPORTUNISTIC BUY. Conviction Score: 59/100. The view would upgrade on a clean Iridium close combined with a Neutron test flight in the first half of 2027, and would degrade on a material launch failure, contract loss or a dilutive equity raise to fund the acquisition.

Wait for entry. Current price USD 82.83 is 30.1% above the buy ceiling of USD 63.67. New positions only below the ceiling.

AWAIT ENTRYOPPORTUNISTIC BUY · 59/100Now USD 82.83 · buy ≤ USD 63.67 · trim ≥ USD 95.00

Thesis break: A failed Neutron first flight, a material contract loss, or a dilutive equity raise materially larger than expected to fund the Iridium acquisition would invalidate the thesis.

Business Model

Rocket Lab generates revenue from two principal segments: Launch Services and Space Systems. Launch Services revenue is recognised on a per-mission basis for Electron flights and, over time, Neutron flights, with customers spanning commercial constellation operators, civil agencies and US national security buyers. Space Systems revenue is derived from the design and manufacture of satellite hardware, including the SolAero solar array business and structural components, sold to commercial and government prime contractors.

The Q1 2026 results, filed with the SEC on 8 May 2026, recorded record quarterly revenue of $200.35 million and a backlog of approximately $2.2 billion, giving meaningful visibility into medium-term revenue. Management has guided Q2 2026 revenue to $225 - 240 million with a non-GAAP gross margin of 38 - 40%, implying roughly 16% sequential growth at the midpoint and a rising profitability profile as launch mix matures. Profitability remains negative at the headline level, with a trailing P/E of -254.24 reflecting ongoing investment in Neutron and acquired capability rather than a steady-state earnings base.

The competitive moat is built on three pillars: a proven flight heritage with Electron, a vertically integrated supply chain that captures more value per mission than broker-style rivals, and privileged access to US national security launch demand through existing contracts and security clearances. The moat is narrow at present - SpaceX's Falcon 9 dominates the medium-lift market and several well-funded small-launch peers are approaching first flight - and depends on Rocket Lab executing Neutron on schedule and absorbing the Iridium transaction without margin dilution.

Financial Snapshot

Price

USD 82.83

Market Cap

USD 49.5bn

52w High

USD 151.00

52w Low

USD 37.57

Distance from 52wH

-45.1%

Beta

2.60

Avg Volume

21094350

Currency

USD

Recent Catalysts

[8 May 2026] - Rocket Lab reported record Q1 FY2026 revenue of $200.35 million, with management guiding Q2 2026 revenue to $225 - 240 million and a $2.2 billion backlog disclosed alongside the print. Source: Rocket Lab 8-K filing (SEC).

[8 May 2026] - The company signed the largest launch contract in its history, reinforcing the national security and commercial launch backlog ahead of the next earnings period. Source: Rocket Lab Q1 2026 earnings release and The Motley Fool earnings transcript (8 May 2026).

[29 June 2026] - Rocket Lab filed an 8-K announcing the proposed acquisition of Iridium Communications, framed as an historic deal expanding the company's satellite infrastructure footprint. Source: Rocket Lab Corporation 8-K filing (SEC), filed 29 June 2026.

[Q2 2026 outlook] - Non-GAAP gross margin guidance of 38 - 40% and GAAP gross margin guidance of 33 - 35% signal that the margin trajectory remains positive as launch and Space Systems mix matures. Source: Rocket Lab Q1 2026 earnings release and 8-K filing (SEC, 8 May 2026).

Thesis Evaluation

Bull Case (25% weight)

The Iridium acquisition closes on schedule in late 2026 or early 2027 and contributes incremental recurring revenue, lifting the run-rate above $1.2 billion by FY2027. Neutron reaches a successful first flight in 2027 and the Space Force contract converts into recurring launches, with the backlog re-rating as multi-year guarantee. Price target: $130 over a 12-month horizon.

Base Case (51% weight)

Rocket Lab executes its existing Electron manifest, delivers Q2 2026 revenue in the $225 - 240 million guided range and closes the Iridium transaction with modest revenue contribution from FY2027. Margins continue to expand toward non-GAAP break-even by late 2027, with the share price reflecting both the acquisition and the Neutron development pathway. Price target: $95 over a 12-month horizon.

Bear Case (24% weight)

Neutron slips materially, Iridium integration erodes margin, and a launch failure or lost Space Force contract compels a dilutive raise to fund the next phase of growth. Hype-driven buyers rotate out as revenue growth decelerates below 15% and gross margin guidance is cut. Price target: $48 over a 12-month horizon.

Weighted conviction:Bull (25%) x 100 + Base (51%) x 62 + Bear (24%) x 10 = 59/100. OPPORTUNISTIC BUY.

Key Risks

Execution risk on rapid growth and integration: The 10-K explicitly warns that failure to manage rapid growth could materially harm operations and financial results, with integration of the Iridium transaction amplifying this risk. Estimated probability: 35%. Impact: severe.
Continued GAAP losses and dilutive financing: A trailing P/E of -254.24 means sustained operating losses, creating a credible risk of further equity issuance to fund Neutron and the Iridium deal. Estimated probability: 30%. Impact: moderate.
Launch failure or vehicle development setback: A failure on Electron or a major setback in Neutron development would disrupt the launch cadence underpinning the $2.2 billion backlog and the Space Force contract. Estimated probability: 15%. Impact: severe.
Competitive pressure from SpaceX and emerging small-launch peers: Aggressive pricing from SpaceX and progress by rival small-launch operators could compress launch pricing power and Space Systems margins. Estimated probability: 40%. Impact: moderate.
Customer concentration in national security backlog: Heavy reliance on US Space Force and other defence customers creates exposure to budget cycles and contract re-competes. Estimated probability: 25%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: growth-oriented investors with a minimum 18 - 24 month holding horizon, a high tolerance for volatility and the capacity to absorb continued GAAP losses while Rocket Lab scales. The position suits a thematic satellite-to-launch portfolio weighting where the investor is comfortable valuing the company on revenue growth and backlog rather than trailing earnings, and can accept the binary risk attached to Neutron's first flight and the Iridium transaction close.

Avoid if: you require current profitability, dividend income, or a low-beta portfolio profile; if you cannot tolerate single-name drawdowns of 30 - 50% on launch news; or if your mandate prohibits exposure to loss-making, high-issuance growth equities. Conservative income investors and those with a 6 - 12 month horizon should look elsewhere.

Recommendation

OPPORTUNISTIC BUY - 59/100. The rating reflects hard catalysts - the Iridium acquisition and the largest launch contract in company history - set against a credible execution and dilution risk profile flagged in the 10-K. The call would upgrade to a higher-conviction tier on a clean Iridium close combined with a Neutron test flight on schedule, and would downgrade on a Neutron setback, a major launch failure, or a dilutive raise materially larger than the market currently expects. Sizing should remain modest given the negative trailing P/E and binary nature of the next twelve months. At the current price of $82.83 the shares trade above our buy ceiling of $63.67: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $92.47, 12% above the current price of $82.83 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $63.67 - below this level the upside to the base-case target ($95.00) is at least 2x the downside to the bear case ($48.00), the minimum risk/reward we require before committing new capital.

HOLD

between $63.67 and $95.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $95.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 25%.

SELL

if A failed Neutron first flight, a material contract loss, or a dilutive equity raise materially larger than expected to fund the Iridium acquisition would invalidate the thesis, regardless of price - the bear target of $48.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 59/100. Trend versus prior report: Up.

CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)

Report date	Conviction
2026-08-09	59
2026-07-25	47
2026-06-28	63
2026-05-30	64
2026-04-27	81

See the trade-card view →

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow covering Rocket Lab's Q1 2026 earnings release, accompanying company filings, US national security launch contract announcements, and the announced Iridium acquisition, supplemented by mainstream financial news commentary around the earnings event.

Primary source types: SEC filings (8-K dated 29 June 2026 and 8-K filing of 8 May 2026 quarterly results), company press releases and earnings call transcripts, Rocket Lab's FY2025 10-K risk disclosures, and public regulatory announcements.

Key sources

Data correct as of 2026-08-09